Prof Jean Louis Abdourahim Ndiaye, OPT-SMC project PI in Senegal
Prof Jean Louis Abdourahim Ndiaye, in charge of Monitoring and Evaluation in MARCAD, has been selected to lead the Opt-SMC project, which aims to optimize the delivery and effectiveness of Seasonal Malaria Chemoprevention (SMC).
In the Sahel and sub-Saharan regions of Africa, malaria-related death and serious illness occur mainly among young children during the rainy season, which generally lasts three to five months. SMC helps to ensure a high level of protection against malaria in children during that period.
SMC consists of monthly administration of sulfadoxine-pyrimethamine and amodiaquine to children from three months to five years during the peak of malaria transmission season. In Senegal, the target has been extended to children up to 10 years old.
The Opt-SMC project is a partnership between the University of Thiès in Senegal, the UNDP/UNICEF/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR), Medicines for Malaria Venture (MMV) and the London School of Hygiene and Tropical Medicine (LSHTM).
Read more: Prof Jean Louis Abdourahim Ndiaye, OPT-SMC project PI in Senegal
The MARCAD Programme contributes in the fight against COVID-19 at the Faculty of Medicine/UCAD
The Malaria Research Capacity Development (MARCAD) programme at UCAD has donated personal protective materials to the Faculty of Medicine, Pharmacy and Odontology (FMPO) of the Cheikh Anta Diop University, on Monday 24th August, to support the Senegal national COVID-19 response.
Barriers to malaria interventions in Ghana
Matilda Aberese-Ako is a medical anthropologist and MARCAD postdoctoral researcher at the University of Health and Allied Sciences (UHAS) in Ghana. The Malaria Research Capacity Development Consortium (MARCAD) research programme is supported by the Developing Excellence, Leadership and Training in Science in Africa (DELTAS Africa). MARCAD is one of the 11 DELTAS Africa programmes. DELTAS Africa funds collaborative networks/consortia led by Africa-based scientists to amplify Africa-led development of world-class research and scientific leaders on the continent, while strengthening African institutions. DELTAS Africa is implemented through AESA (The Alliance for Accelerating Excellence in Science in Africa), a funding, agenda setting and programme management platform created by the African Academy of Sciences (AAS) and the African Union Development Agency (AUDA-NEPAD) and with the support of Wellcome and the UK’s Department for International Development (DFID).
Exclusif ! Pr Oumar Gaye, co-signataire de la lettre des scientifiques à la revue The Lancet : « Ce que nous reprochons à l’étude de Lancet sur la Chloroquine (…) Un protocole pour l’utilisation de la chloroquine en prévention est déposé au Sénégal »
La parution d’une analyse rétrospective remettant en question l’efficacité de la chloroquine et de son dérivé l’hydroxychloroquine dans le traitement de la Covid-19 a fait sortir une centaine de scientifiques de leur silence. À travers une lettre ouverte, ces têtes bien faites ont demandé des comptes aux auteurs de ladite « étude » publiée dans la revue anglaise The Lancet vendredi 22 mai. Parmi eux, le Pr Oumar Gaye. Ancien chef du service Parasitologie médicale de la Faculté de Médecine de l’Université Cheikh Anta Diop, ce membre de l’Académie Nationale des Sciences et Techniques du Sénégal (ANSTS), qui dirige actuellement le Malaria Research Capacity Development Consortium en Afrique de l’Ouest et du Centre (MARCAD), a accepté pour Dakaractu, de revenir sur les raisons qui l’ont poussé à s’associer à une telle démarche. Dans le même temps, le scientifique encourage le Sénégal à maintenir son traitement basé sur l’hydroxychloroquine et révèle à votre site que ses collaborateurs ont déposé un protocole devant le comité d’éthique pour l’utilisation de la chloroquine en prévention pour les groupes à risque exposés à la COVID-19. Entretien...
ASTMH 2019, Oumar Gaye: "Malaria Elimination within a Universal Health Coverage"
In collaboration with ASTMH, Image Audiovisuals, and session presenters, MESA brings you this webcast from the 68th ASTMH annual meeting in Maryland, November 2019
Title: “Malaria Elimination within a Universal Health Coverage”
Speaker: Oumar Gaye, Universite Cheikh Anta Diop, Dakar, Senegal (watch the video)
Session information:
Symposium 141: African-Led Perspectives on Programmatic Challenges to Malaria Elimination
November 23, 2019, 1:45 PM - 3:30 PM, Potomac C (Ballroom Level)
Read more: ASTMH 2019, Oumar Gaye: "Malaria Elimination within a Universal Health Coverage"
More Articles ...
- MARCAD Secretariat hosts the London School of Hygiene & Tropical Medicine (LSHTM)’s delegation
- MARCAD supports the National Academy of Young Scientists of Senegal (ANJSS) for the capacity building of its members.
- In Focus: International Day of Women and Girls in Science
- Remarkable MARCAD participation at the 68th ASTMH Conference 2019 in Maryland
Subcategories
Latest News
PUBLIC AND COMMUNITY ENGAGEMENT
Contact Us
MARCAD Consortium Secretariat
Faculty of Medicine, Pharmacy and Odontology
University Cheikh Anta Diop (UCAD) of Dakar, Senegal
